A major clinical trial has shown that changing the way radiotherapy is delivered could significantly reduce the side effects associated with radiotherapy treatment for prostate cancer.

Taking a ‘fingerprint’ of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study shows.

Men with ‘high risk’ prostate cancer can safely receive high-dose radiotherapy to kill cancer cells that have spread into neighbouring lymph nodes, a new study reports.